Condition-Specific Health
Survodutide Phase III Cuts Visceral Fat 34%, Liver Fat 63% in Obesity Trials
Results published simultaneously in NEJM and Nature Medicine signal a new mechanistic benchmark for metabolic-health fo…
All 517 stories
![SlimTide Capsules [UPDATED WARNING 2026] Slim Tide Uncovering the Real Truth Behind the Trending Weight Loss Supplement](/public/functional/uploads/exogenous-ketone-supplements-under-scrutiny-as-bhb-claims-multiply-hero.png)
Condition-Specific Health
Exogenous Ketone Supplements Under Scrutiny as BHB Claims Multiply
With BHB blends flooding e-commerce channels, operators and formulators face mounting pressure to substantiate ketone-d…
Condition-Specific Health
Men's Vitality Supplement Category Draws Scrutiny as Claims Multiply
As the men's wellness segment expands, operators and formulators face tightening expectations around evidence-based pos…
Condition-Specific Health
CLN-978 T Cell Engager Shows Remissions in SLE and RA Trial
Early-phase data presented at EULAR 2026 positions B-cell depletion as a credible mechanism in autoimmune disease manag…
Ingredients & Formulation
Inhaled Insulin Afrezza Posts New Data Across Pediatric and AID Use
New data across three high-complexity populations could reshape how formulators and clinicians think about insulin-deli…
Condition-Specific Health
Ribupatide Phase Data Surfaces at ADA 2026 via Hengrui-Kailera
As the metabolic health ingredient space watches GLP-1 mimetic botanicals gain shelf space, pharma-grade peptide data c…
Condition-Specific Health
Icovamenib Posts HbA1c, C-Peptide Gains in Type 1 Diabetes Trial
Biomea Fusion also flags muscle-preservation and fat-reduction signals, positioning the menin inhibitor as a potential …
Industry & Business
Banner Health Names Chief AI Officer to Modernize Data Infrastructure
Health system AI buildouts are reshaping how ingredient suppliers, clinical researchers, and nutraceutical brands acces…
Condition-Specific Health
Memocept Nootropic Stack Faces Customer Complaints and Efficacy Scrutiny
The episode underscores persistent industry pressure to back cognitive structure-function claims with peer-reviewed cli…
Science & Research
DR3-Blocking Antibody SL-325 Phase 1 Data Set for June 8 Readout
The readout covers tolerability, receptor occupancy, and immunogenicity endpoints — key signals for a mechanism with po…
Condition-Specific Health
Rivus Pharma's Oral GLP-1 Candidate Shows Muscle-Preserving Effects in Preclinical Data
As GLP-1 weight-loss agents reshape the metabolic health market, lean-mass retention emerges as a key functional differ…
Regulatory & Policy
Quebec Energy Drink Youth Bill Press Release Retracted
The retraction leaves the regulatory status of Quebec's proposed energy drink age-restriction legislation unclear for C…